USPTO serial 74217936
ASTA MEDICA
Reviewed by CopyMark Law Group
Reg. 1815589Status 710
- Filing date
- Status date
- Registration date
- Jan 11, 1994
- Examiner
- MULLEN, MARK
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with ASTA MEDICA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
ASTA Medica Aktiengesellschaft
D-6000 Frankfurt a.M. 1, DE
ASTA Medica Aktiengesellschaft
D-6000 Frankfurt a.M. 1, DE
ASTA Medica Aktiengesellschaft
D-6000 Frankfurt a.M. 1, DE
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | chemicals for use in scientific and medical research, development and production of pharmaceutical products | SECTION 8 - CANCELLED | — |
| 003 | [ cosmetics; namely, perfume, body lotions, skin lotions and cremes, bath and toilet soaps, cream bath, shampoos, hair lotions, dentrifices, throat sprays and mouthwashes for non-medical use and breath fresheners ] | SECTION 8 - CANCELLED | — |
| 005 | pharmaceutical preparations; namely, [ anorectics for the treatment of anorexia, analgetics/antirheumatics for the treatment of pains, antiallergics for the treatment of allergic diseases, antidotes for the treatment of toxicity and poisoning, antiemetics/antivertiginousics for the treatment of hyperemesis, vomiting, motion sickness, antihypertonics (antihypertensives) for the treatment of hypertension, antitussives/expectorants for treatment of all kinds of coughs and mucous diseases, balneotherapeutics for the treatment of dermatopathy, dermatitis, betablockers used in the treatment of cardiac and cardiovascular diseases, ace-inhibitors used in the treatment of cardiac and cardiovascular diseases, broncholytics/antiasthmatics used in the treatment of diseases of the respiratory tract, dermatics used in the treatment of all kinds of dermatic diseases, diagnostics reagents for clinical or medical laboratory use, diuretics for treatment of diuresis and hypertension, cardioactive agents used for the treatment of cardiac and cardiovascular diseases, coronary agents (vasodilators) for use in the treatment of coronary heart diseases, hepatica agents for use in the treatment of hepatic diseases, gastrointestinal agents for use in the treatment of gastrointestinal diseases, migraine agents for use in treatment of migraine and headaches, mouth and throat therapeutics, muscle relaxants, opthalmics for use in the treatment of ophthalmic diseases, preparations for the treatment of Parkinson's disease and against extrapyramidal disorders, psychotropic drugs for the treatment of psychotropic and psychotic diseases, rhinologics for use in the treatment of diseases of the respiratory tract, thyroid therapeutics; sera for clinical or medical laboratory use, immunoglobins for clinical or medical laboratory use; vaccines for use in the prevention of viral influenza for human use, sexual hormones and their inhibitors, ] cytostatic agents for use in the treatment of cancer, oncosis and carcinolysis, [ vitamin and mineral supplements, and phytotherapeutics for use in the treatment of all kinds of inflammatory diseases as well as dermatic diseases ] | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by ASTA Medica Aktiengesellschaft
- Other trademarks owned by ASTA Medica Aktiengesellschaft
- Other trademarks owned by ASTA Medica Aktiengesellschaft
- Other trademarks in Class 001
- Other trademarks in Class 003
- Other trademarks in Class 005
- Similar marks named ASTA MEDICA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 16, 2004 | CAEX | CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 | — |
| Apr 3, 2000 | C15P | REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Dec 17, 1999 | 815F | REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED | — |
| Jan 11, 1994 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 3, 1993 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 2, 1993 | NPUB | NOTICE OF PUBLICATION | — |
| May 17, 1993 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 29, 1993 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 30, 1992 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 18, 1992 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 23, 1992 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 28, 1992 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 21, 1992 | DOCK | ASSIGNED TO EXAMINER | — |